[Abstract] Cdk5 activity is regulated by the amounts of two activator proteins, p35 and p39 (Tsai et al., 1994; Zheng et al., 1998; Humbert et al., 2000) . The p35-Cdk5 and p39-Cdk5 complexes have differing sensitivity to salt and detergent concentrations (Hisanaga and Saito, 2003; Sato et al., 2007; Yamada et al., 2007; Asada et al., 2008) . Cdk5 activation can be directly measured by immunoprecipitation of Cdk5 with its bound activator, followed by a Cdk5 kinase assay. In this protocol, buffers for cell lysis and immunoprecipitation are intended to preserve both p35-and p39-Cdk5 complexes to assess total Cdk5 activity. Cells are lysed and protein concentration is determined in the post-nuclear supernatant. Cdk5 is immunoprecipitated from equal amounts of total protein between experimental groups. Washes are then performed to remove extraneous proteins and equilibrate the Cdk5-activator complexes in the kinase buffer. Cdk5 is then incubated with histone H1, a well-established in vitro target of Cdk5, and demonstrated that Cdk5 also regulates oligodendroglia progenitor cell (OPC) development (Tang et al., 1998; Miyamoto et al., 2007 and . Cdk5 function is critical for OPC migration and differentiation, and loss of Cdk5 results in CNS hypomyelination (Miyamoto et al., 2007 and He et al., 2010; Yang et al., 2013) . However, molecular mechanisms that regulate Cdk5 function in neurons and OLs remain elusive. The activity of Cdk5 is controlled by the available amounts of two activator homologs, p35 and p39 (Tsai et al., 1994; Zheng et al., 1998; Humbert et al., 2000) . The defects in embryonic brain development and perinatal lethality observed in mice lacking both p35 and p39 were nearly identical to defects in the Cdk5-null mice (Ohshima et al., 1996; Ko et al., 2001) , indicating that p35 and p39 are the sole activators of Cdk5 in the brain. We uncovered that in contrast to the major role of p35 in activating Cdk5 in neurons, p39 is the primary Cdk5 activator in oligodendrocytes (OLs), where p35 expression is negligible. Using this active Cdk5 immunoprecipitation and kinase assay, we demonstrated that Cdk5 activity is almost completely ablated in OLs with siRNA-mediated p39 knockdown. Previous work established the differing sensitivity of p35 and p39 to high detergent and salt concentrations (Hisanaga and Saito, 2003; Sato et al., 2007; Yamada et al., 2007; Asada et al., 
www.bio-protocol.org/e2363 A. Generating cellular lysates 1. Cell cultures should be grown to confluence with the appropriate treatment and control groups.
2. Aspirate the media from the plate(s) and rinse the cell cultures very gently with PBS (see Recipes) twice. Remove the PBS from the last wash.
3. Detach the cells from the culture plates using a cell lifter. Collect the detached cells by rinsing the plate with an appropriate volume of PBS (1 ml for 60 mm plates, 3 ml for 100 mm plates,
etc.).
4. Transfer the cell suspension to a 15 ml conical tube.
5. Centrifuge the cell suspension at 3,500 x g for 5 min at 4 °C.
6. Repeat steps A3-A5 if needed.
7. Resuspend the cell pellets in lysis buffer (see Recipes) at 15% w/v.
8. Incubate lysates on ice for 10 min with periodic agitation. proteins that non-specifically bind to the beads.
5. Centrifuge the mixture at 3,000 x g for 2 min at 4 °C.
6. Transfer the supernatant to a fresh tube.
7. Quantify the concentration of protein in the lysate using standard protein quantification methods (Bradford or BCA kits, for example) a. Generate a standard curve of 1 mg/ml, 0.5 mg/ml, 0.25 mg/ml, 0.125 mg/ml, and 0 mg/ml bovine serum albumin (BSA) by diluting it using sterile water.
b. Dilute the lysate (between 1:2 to 1:10 for cell lysate) so that the sample protein concentration will fall within the range of the BSA standard curve.
c. Follow the manufacturer's instructions to record the concentration of protein in the lysate.
Take note of the R 2 value as it indicates the accuracy of the protein concentration quantification (0.9 and above is desired).
d. Take the average of three readings.
C. Immunoprecipitating the Cdk5/activator complex 1. Prepare two fresh 1.5 ml tubes with 1 mg of total protein from the lysate. 6. Add 50 µl of 50% slurry of Protein A beads to each tube.
7. Rotate or rock the mixture of beads and lysate at 4 °C for 2 h.
8. Centrifuge the tubes at 3,000 x g for 2 min at 4 °C.
9. Remove and discard the supernatant.
10. Add 500 µl of lysis buffer containing 0.1% NP-40.
11. Rotate or rock the mixture of beads and lysate at 4 °C for 10 min.
12. Repeat steps C8-C11 twice more.
13. Centrifuge the tubes at 3,000 x g for 2 min at 4 °C.
14. Remove and discard the supernatant.
15. Add 500 µl of kinase buffer (see Recipes) without ATP or histone H1.
16. Rotate or rock the mixture of beads and lysate at 4 °C for 10 min.
17. Repeat steps C13-C16 once more (general scheme of immunoprecipitation in Figure 2 ). c. Add 10 mM ATP to bring the total volume to 50 µl.
4. Add 10 µl of the 32 P mix from step D3 to the positive control reaction prepared in step D2.
5. Add 2 µl of 32 P mix from step D3 to each IP reaction from step D1.
6. Mix 25 µl of kinase buffer with 2 µl of 32 P mix from step D3 as a negative control.
7. Incubate all reactions at 30 °C for 30 min. www.bio-protocol.org/e2363 11. DO NOT allow the dye front to exit the bottom of the gel. This will minimize radioactive contamination of the running buffer or equipment.
12. After resolving reactions, cut off dye at bottom (contains free 32 P) and stacking gel.
13. Transfer the resolved proteins to nitrocellulose or PVDF membrane.
14. Expose the membrane to film or phosphorscreen at -80 °C (see example in Figure 4 ).
Figure 4. Detection of Cdk5 kinase activity and protein levels in immunoprecipitates.
Results of Cdk5 immunoprecipitation and kinase assay performed from cells transfected with control siRNA with empty vector (Ctrlsi + pc), p39 siRNA with empty vector (p39si + pc), p39
siRNA with p39-FLAG (p39si + p39F). Kinase buffer alone was included as a negative control.
In this figure, the exogenously expressed p39-FLAG reversed the effect on Cdk5 activity caused by siRNA-mediated knockdown of endogenous p39. This research was originally 5. Wash the membrane by incubating it in PBS-T for 10 min.
6. Discard the PBS-T wash solution.
7. Repeat steps E5-E6 twice more.
8. Incubate the membrane with 2% non-fat milk in PBS-T containing a 1:5,000 dilution of HRP-conjugated anti-rabbit IgG antibody (Jackson ImmunoResearch) at room temperature for one hour.
9. Wash the membrane by incubating it in PBS-T for 10 min.
Discard the PBS-T wash solution.
www.bio-protocol.org/e2363 12. Expose the membrane to film (see example in Figure 4 ).
Data analysis
1. For experimental design, the immunoprecipitation and kinase assay is performed a minimum of three times for a given experiment.
2. Densitometric analysis is performed using ImageJ. For each sample the intensity of histone H1 phosphorylation measured in step D13 is normalized to the intensity of Cdk5 protein measured in step E12 (see Figure 5 ). 3. We include two obligate controls in this protocol: 1) active Cdk5/p25 complex as a positive control; 2) kinase buffer only group as a negative control to ensure reagent purity. Other controls which are specific to your experiment should be considered.
4. This assay should be used in combination with Western blot for phosphorylated and total levels of known Cdk5 targets in lysates of your cells to confirm any changes observed in Cdk5 activity.
5. When rescuing expression of a target of siRNA-mediated knockdown (for example, p39 in this protocol), it is optimal to use an expression vector (p39F) that contains silent point mutations in the sequence which is targeted by the siRNA (p39si). This will make the rescue expression vector resistant to the siRNA. 
